Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
iNO in Post-PE Syndrome
NCT04920695Completed
- Start
- May 2021
- Primary completion
- May 2023
- Modality
- DNA Intercalators/Alkylators, Inhalation Devices
- Countries
- 1
01
Overview
Randomised, double-blind trial in Post-Pulmonary Embolism Syndrome (PPES) comparing Placebo Control with Inhaled Nitric Oxide (2 arms). Primary endpoints: Dyspnea Intensity, Leg discomfort Intensity and 1 more. Started May 2021; status: completed.
02
Drugs
nitric oxide
03
Conditions
Post-Pulmonary Embolism Syndrome (PPES)
Beyond the preview
Go deeper on NCT04920695.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04920695.